Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants

Blocking androgen receptor (AR) transcriptional activity by androgen deprivation therapy (ADT) improves the response to radiotherapy for intermediate and high risk prostate cancer. Unfortunately, ADT, antiandrogens, and abiraterone increase expression of constitutively active splice variants of AR (...

Descripción completa

Detalles Bibliográficos
Autores principales: Banuelos, Carmen A., Ito, Yusuke, Obst, Jon K., Mawji, Nasrin R., Wang, Jun, Hirayama, Yukiyoshi, Leung, Jacky K., Tam, Teresa, Tien, Amy H., Andersen, Raymond J., Sadar, Marianne D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409302/
https://www.ncbi.nlm.nih.gov/pubmed/32708219
http://dx.doi.org/10.3390/cancers12071991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409302/
https://www.ncbi.nlm.nih.gov/pubmed/32708219
http://dx.doi.org/10.3390/cancers12071991

Ejemplares similares